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I read with great interest the recent publi-
cation of Humpl and colleagues1 in the
Journal and found it to contain intriguing
data and several conclusions that require
further clarification. In particular, I wish to
comment on (1) methodologic aspects of
exhaled nitric oxide (NO) measurements in
patients with mechanical ventilation, (2)
the anatomic origin of exhaled NO, and
whether it can be used readily as a measure
of endothelial dysfunction, (3) whether car-
diopulmonary bypass (CPB) unequivocally
causes reduction of exhaled NO, and (4)
whether pulmonary blood flow influences
exhaled NO in human beings. I believe that
these issues are more controversial than
presented in this article.
Exhaled NO is now an approved clini-
cal diagnostic tool to monitor airway in-
flammation in patients with asthma; how-
ever, this approval was preceded by
international consensus on methodologic
aspects of exhaled NO measurements in
spontaneously breathing patients. Both the
European Respiratory Society and the
American Thoracic Society have recog-
nized the extreme air flow dependence of
the obtained NO concentrations and have
made recommendations to standardize
technical aspects of the measurement to
ensure comparability of data reported by
different groups. Although the application
of these measurements to surgical or criti-
cally ill patients with mechanical ventila-
tion is increasing, there are currently dif-
ferent approaches, including real-time
breath by breath monitoring, breath hold-
ing maneuvers, and, as represented by the
study of Humpl and colleagues,1 manual
withdrawing of expiratory sample. This
variation makes establishment of reproduc-
ibility and reference values difficult, and
comparing data among different groups im-
possible.
Although it would be premature to con-
clude that real-time monitoring of expired
NO in the gaseous phase, capable of resolv-
ing the NO trace throughout the entire re-
spiratory cycle2,3 (Figure 1), is superior to
other methods, analysis of this approach
highlights a number of problems with man-
ual withdrawal techniques. In patients with
mechanical ventilation the standard expira-
tory flow rate (the main component of Eu-
ropean Respiratory Society and American
Thoracic Society recommendations) cannot
be guaranteed, and thus the changing expi-
ratory flow pattern produces a continuously
variable concentration of NO in the gas
phase (Figure 1). Studies that use real-time
measurements can usually overcome this
problem by calculating the area under
curve or, in case of simultaneous flow mea-
surement, by calculating NO excretion rate.
It is obvious that it would require precise
timing of the beginning and end of expira-
tion by manual approaches to reproduce the
accuracy of the on-line method, otherwise
the data obtained would become somewhat
of a lottery.
This methodologic issue appears to be
crucial, because a similar study on septal
defect closure by Tworetzky and cowork-
ers (cited by the authors),4 which was per-
formed by the on-line method, found an
opposite response in exhaled NO. I find it
somewhat disturbing that with this recog-
nition Humpl and colleagues1 were satis-
fied with averaging only two samples for
each data point.
Humpl and colleagues’ statement and
conclusion that changes in exhaled NO lev-
els reflect endogenous production by the
pulmonary vascular endothelium1 appears
to ignore the current intense debate in the
scientific community regarding the ana-
tomic and cellular origin of exhaled NO,
which is represented by studies and edito-
rials in leading journals. In fact, the current
understanding favors the hypothesis that
basal exhaled NO mainly represents airway
epithelial NO generation, with very little
contribution from the vascular compart-
ment and endothelium under normal con-
ditions.5 This does not exclude the obser-
vations that increased endothelial NO
during the application of endothelium-de-
pendent vasodilators or NO donors are ca-
pable of increasing exhaled NO under stim-
ulated conditions.6 However, in light of
recent data that effective inhibition of en-
dothelial NO metabolism by NO synthase
inhibitors (judged by increased vascular
pressure) did not reduce exhaled NO in
human beings,5 it is extremely difficult to
envisage a mechanism whereby partial at-
tenuation of endothelial NO pathways
(which might indeed occur after CPB)
would be reflected in exhaled NO. The
likely scenario is that a decrease in endo-
thelial NO remains undetectable by ex-
haled NO, and any observed change in
exhaled NO likely represents events in the
airway compartment, such as in the asth-
matic airway.
In addition, Humpl and colleagues’ dis-
cussion regarding the influence of CPB1
appears to be a misrepresentation of the
available literature data. An easy PubMed
search on exhaled NO and extracorporeal
circulation or CPB reveals several publica-
tions, of which at least two studies pub-
lished in The Lancet2 and Critical Care
Medicine3 demonstrated no change in ex-
haled NO after CPB, and a number of stud-
ies where NO was actually increased. Thus
although we all seem to agree that there are
inflammatory events in the lung after CPB
that are likely to involve NO, the relation-
ship between these events and exhaled NO
is not always straightforward.
Finally, Humpl and colleagues1 con-
cluded that exhaled NO levels are indepen-
dent of changes in pulmonary blood flow.
This notion can be readily disputed by data
obtained during monitoring of real-time
NO levels in the lower airways of intubated
patients who were ventilated with standard-
ized ventilation settings and underwent
rapid changes in pulmonary artery blood
Figure 1. Representative traces depicting influence of reduction of pulmonary arterial
blood flow at onset of CPB on exhaled NO and carbon dioxide (CO2).
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flow, such as during instrumentation of
CPB. Figure 1 demonstrates that as pulmo-
nary blood flow decreases, as evidenced by
carbon dioxide delivery, exhaled NO con-
centrations increased. Summary data from
7 patients indicate that reduction of pulmo-
nary arterial blood flow at the onset of CPB
increases peak exhaled NO levels from 7.4
 1.2 ppb to 13.7  1.5 ppb. These data
confirm in human beings earlier sugges-
tions that pulmonary blood flow is not re-
quired for exhaled NO, which is produced
locally in the lung, and that gas-phase NO
concentrations are influenced by uptake
into the pulmonary circulation and blood.
Where do we go from here? This dis-
cussion highlights the fact that Humpl and
colleagues1 have undertaken a complex
task in attempting to delineate the complex
influence of changes from supernormal to
normal pulmonary blood flow and CPB-
associated partial and transient ischemia-
reperfusion and systemic inflammatory re-
sponse on the pulmonary release of NO
from its many sources. Although exhaled
NO could represent an exciting novel diag-
nostic tool to monitor biochemical events
of crucial importance to cardiac surgery,
important methodologic issues that re-
main.7,8 Moreover, even at this early stage
it is obvious that there will be crucial lim-
itations of the methodology. More con-
trolled studies and continued dialog with
international consensus and society recom-
mendations are needed to clarify these is-
sues in ventilated and critically ill patients.
(Exhaled Biomarkers in mechanically ven-
tilated patients [submitted ATS/ERS
Project, Marczin N, Gustafsson LE, Er-
zurum SC, Choi AM, Risby T, and Schu-
bert J]).
Nandor Marczin, MD, PhD
Harefield, United Kingdom
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Reply to the Editor:
We thank Dr Marczin for his interest in our
work1 and the Editor for an opportunity to
respond.
The first issue raised concerns the meth-
odology of exhaled nitric oxide (NO) anal-
ysis. There are several ways to measure
exhaled NO at a constant flow rate in the
sedated, intubated, and mechanically ven-
tilated patient. These include syringe aspi-
ration sampling as performed by us,1 tidal
breathing profiles, and single-breath con-
trolled-flow techniques.2 The latter is dif-
ficult to apply outside the neonatal period.
We chose the syringe aspiration sampling
method because in our preliminary investi-
gations we found it to be a robust, repro-
ducible technique. Indeed, we confirmed
the reproducibility of the method by find-
ing similar changes after cardiopulmonary
bypass in a previous study investigating
exhaled NO before and after surgical clo-
sure of left-to-right shunts in children.3 In
the most recent study1 we measured ex-
haled NO in an identical manner in both
groups of patients, which suggests that the
observed differences between groups were
independent of the method of NO sam-
pling. The results of Tworetzky and col-
leagues4 are intriguing and fully discussed
elsewhere.1
The next concerns raised by Marczin
are the anatomic origin of exhaled NO and
the relationship to endothelial events. Low
exhalation single-breath flow rates (50
mL/s) are characterized by most exhaled
NO arising in airways by diffusion,
whereas higher flows contain a larger pro-
portion of NO arising in the distal lung.5,6
The syringe sampling was performed to-
ward the end of a mechanical tidal breath,
when flows are high. Thus the exhaled
breath will contain a higher proportion of
NO arising in the alveolar region than
would a slow single-breath exhalation. We
suggest that NO produced in the endothe-
lium of the pulmonary capillary bed may
enter the alveolar space and is reflected in
air sampled distally. Capillary blood vol-
ume has been shown to correlate with ex-
haled NO.7 Notwithstanding the elegant
study by Sartori and coworkers,8 which
was performed in healthy adults, there is
evidence to suggest that endothelial de-
rived NO at least partly contributes to ex-
haled NO levels in cardiovascular dis-
ease.9,10 Indeed, Marczin’s published
position is equivocal on this subject, some-
times for11 and sometimes against.
The influence of cardiopulmonary by-
pass on exhaled nitric oxide levels is likely
to be complex and dependant on the dis-
ease, the surgical procedure performed as
well as the timing of the measurements.
Thus Marczin’s cited examples of adults
undergoing lung transplantation12 or coro-
nary artery surgery with bronchoalveolar
lavage13 may not be comparable to chil-
dren with congenital heart disease. Indeed,
our study is perhaps unique in that cardiac
correction was achieved with the use of
bypass in one group and without in an-
other. The changes in exhaled nitric oxide
thus can be more certainly attributed to
cardiopulmonary bypass than is possible in
other studies.
The changes in pulmonary blood flow
during cannulation for cardiopulmonary
bypass described by Marczin are fascinat-
ing, and we are certain his group will have
the opportunity to submit them for peer
review. However, they are irrelevant to the
investigation we undertook and to our con-
clusions. Stated simply, after closure of an
atrial septal defect exhaled nitric oxide ei-
ther increases or decreases, and it is the
method of closure and sequelae (surgery vs
transcatheter), rather than the hemody-
namic consequence of closure (reduction in
pulmonary blood flow) that influences the
direction of change.
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